171 related articles for article (PubMed ID: 34547796)
1. Hereditary Breast and Ovarian Cancer Screening Syndrome Profile in Women Diagnosed with Breast Cancer from Paraná State Southwest.
Moura JB; Ghedin CC; Takakura ÉT; Scandolara TB; Rech D; Panis C
Rev Bras Ginecol Obstet; 2021 Aug; 43(8):616-621. PubMed ID: 34547796
[TBL] [Abstract][Full Text] [Related]
2. Use of a Standardized Tool to Identify Women at Risk for Hereditary Breast and Ovarian.
Hessock M; Brewer T; Hutson S; Anderson J
Nurs Womens Health; 2021 Jun; 25(3):187-197. PubMed ID: 33933425
[TBL] [Abstract][Full Text] [Related]
3. Increasing referral of at-risk women for genetic counseling and BRCA testing using a screening tool in a community breast imaging center.
Arun BK; Peterson SK; Sweeney LE; Bluebond RD; Tidwell RSS; Makhnoon S; Kushwaha AC
Cancer; 2022 Jan; 128(1):94-102. PubMed ID: 34424535
[TBL] [Abstract][Full Text] [Related]
4. Interdisciplinary risk counseling for hereditary breast and ovarian cancer: real-world data from a specialized center.
Zang B; Helms M; Besch L; Kalmbach N; Stegen S; Blohmer JU; Speiser D
Arch Gynecol Obstet; 2023 May; 307(5):1585-1592. PubMed ID: 36307613
[TBL] [Abstract][Full Text] [Related]
5. Advancing health equity: A qualitative study assessing barriers and facilitators of implementing hereditary breast and ovarian cancer risk screening tools in community-based organizations.
Bowen A; Gómez-Trillos S; Curran G; Graves KD; Sheppard VB; Schwartz MD; Peshkin BN; Campos C; Garcés N; Dash C; Aburto L; Valencia-Rojas N; Hernández G; Villa A; Cupertino P; Carrera P; Hurtado-de-Mendoza A
J Genet Couns; 2023 Oct; 32(5):965-981. PubMed ID: 37062905
[TBL] [Abstract][Full Text] [Related]
6. Identifying Women at Risk for Hereditary Breast and Ovarian Cancer Syndrome Utilizing Breast Care Nurse Navigation at Mammography and Imaging Centers.
Appel SJ; Cleiment RJ
J Natl Black Nurses Assoc; 2015 Dec; 26(2):17-26. PubMed ID: 27045154
[TBL] [Abstract][Full Text] [Related]
7. Hereditary Breast and Ovarian Cancer: An Updated Primer for OB/GYNs.
Bellcross CA
Obstet Gynecol Clin North Am; 2022 Mar; 49(1):117-147. PubMed ID: 35168766
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of Population-Wide Genomic Screening for Hereditary Breast and Ovarian Cancer in the United States.
Guzauskas GF; Garbett S; Zhou Z; Spencer SJ; Smith HS; Hao J; Hassen D; Snyder SR; Graves JA; Peterson JF; Williams MS; Veenstra DL
JAMA Netw Open; 2020 Oct; 3(10):e2022874. PubMed ID: 33119106
[TBL] [Abstract][Full Text] [Related]
9. Young Women's Perspectives on Being Screened for Hereditary Breast and Ovarian Cancer Risk During Routine Primary Care.
Head M; Cohn B; Wernli KJ; Palazzo L; Ehrlich K; Matson A; Knerr S
Womens Health Issues; 2024; 34(3):268-275. PubMed ID: 38448251
[TBL] [Abstract][Full Text] [Related]
10. Mutation screening of TP53, CHEK2 and BRCA genes in patients at high risk for hereditary breast and ovarian cancer (HBOC) in Brazil.
Cipriano NM; de Brito AM; de Oliveira ES; de Faria FC; Lemos S; Rodrigues AN; de Oliveira Lopes D; Dos Santos LL
Breast Cancer; 2019 May; 26(3):397-405. PubMed ID: 30535581
[TBL] [Abstract][Full Text] [Related]
11. Communicating risk of hereditary breast and ovarian cancer with an interactive decision support tool.
Rupert DJ; Squiers LB; Renaud JM; Whitehead NS; Osborn RJ; Furberg RD; Squire CM; Tzeng JP
Patient Educ Couns; 2013 Aug; 92(2):188-96. PubMed ID: 23664232
[TBL] [Abstract][Full Text] [Related]
12. "Are you at risk for hereditary breast cancer?": development of a personal risk assessment tool for hereditary breast and ovarian cancer.
Cohn WF; Jones SM; Miesfeldt S
J Genet Couns; 2008 Feb; 17(1):64-78. PubMed ID: 18181014
[TBL] [Abstract][Full Text] [Related]
13. BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?
Alemar B; Gregório C; Herzog J; Matzenbacher Bittar C; Brinckmann Oliveira Netto C; Artigalas O; Schwartz IVD; Coffa J; Alves Camey S; Weitzel J; Ashton-Prolla P
PLoS One; 2017; 12(11):e0187630. PubMed ID: 29161300
[TBL] [Abstract][Full Text] [Related]
14. Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
Petelin L; James PA; Trainer AH
Intern Med J; 2018 Oct; 48(10):1269-1272. PubMed ID: 30288903
[TBL] [Abstract][Full Text] [Related]
15. Ovarian Cancer in Hereditary Cancer Susceptibility Syndromes.
Nakonechny QB; Gilks CB
Surg Pathol Clin; 2016 Jun; 9(2):189-99. PubMed ID: 27241103
[TBL] [Abstract][Full Text] [Related]
16. Screening of BRCA1/2 genes mutations and copy number variations in patients with high risk for hereditary breast and ovarian cancer syndrome (HBOC).
El Ansari FZ; Jouali F; Marchoudi N; Bennani MM; Ghailani NN; Barakat A; Fekkak J
BMC Cancer; 2020 Aug; 20(1):747. PubMed ID: 32778078
[TBL] [Abstract][Full Text] [Related]
17. Factors influencing genetic counseling and testing for hereditary breast and ovarian cancer syndrome in a large US health care system.
Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
Clin Genet; 2022 Mar; 101(3):324-334. PubMed ID: 34927729
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hereditary breast and ovarian cancer (HBOC) predisposition gene mutations among 882 HBOC high-risk Chinese individuals.
Shao D; Cheng S; Guo F; Zhu C; Yuan Y; Hu K; Wang Z; Meng X; Jin X; Xiong Y; Chai X; Li H; Zhang Y; Zhang H; Liu J; Ye M
Cancer Sci; 2020 Feb; 111(2):647-657. PubMed ID: 31742824
[TBL] [Abstract][Full Text] [Related]
19. Identification of women at risk of hereditary breast-ovarian cancer among participants in a population-based breast cancer screening.
Bonelli L; Valle I; Rebora I; Ricci P; Biocchi L; Bruschi G; Parodi S; Bruzzone C; Varesco L
Fam Cancer; 2022 Jul; 21(3):309-318. PubMed ID: 34669096
[TBL] [Abstract][Full Text] [Related]
20. Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
Brannon Traxler L; Martin ML; Kerber AS; Bellcross CA; Crane BE; Green V; Matthews R; Paris NM; Gabram SG
Ann Surg Oncol; 2014 Oct; 21(10):3342-7. PubMed ID: 25047474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
